secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0000950170-24-072462
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharmaceuticals shareholders elect Kindler and Burroughs as directors; ratify Ernst & Young as auditor
--------------------------------------------------------------------------------

- Jeffrey Kindler elected with 45,958,352 votes for, 6,735,358 withheld, 5,131,121 broker non-votes.
- Amy Burroughs elected with 52,570,019 votes for, 123,691 withheld, 5,131,121 broker non-votes.
- Ernst & Young ratified as independent auditor for FY2024 with 57,570,954 for, 23,950 against, 229,927 abstentions.
- Annual Meeting held June 10, 2024; 64,674,780 shares outstanding and entitled to vote as of record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017024072462/0000950170-24-072462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017024072462/tern-20240610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-072462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer